ZYTIGA ® is used to treat men with prostate cancer that has spread to other parts of the body. It will also notify you if the changes made successfully completed or not via a popup result window. ZYTIGA ® (abiraterone acetate) is a prescription medicine that is used along with prednisone. Any modifications that you make can be overwritten to the original file or saved to a new file. plan or payor, and my pharmacy to disclose certain information about me to Astellas (Company) and its third-party suppliers, vendors, and other service providers supporting Astellas Pharma Support Solutions SM (collectively, the Service Providers). You can also change the page layout and mode. Astellas and does not belong to any one individual, function, business unit, affiliate and/or department. 2.1 Patient Selection 2.2 Recommended Dose NSCLC. 1.1 Non-Small Cell Lung Cancer (NSCLC) 1.2 Pancreatic Cancer.
#Astellas pdf info full
Revised: 05/2013 FULL PRESCRIBING INFORMATION: CONTENTS 1 INDICATIONS AND USAGE. Astellas shall continue the Compliance Program throughout the term of the CIA and shall do so in accordance with the terms set forth below. See 17 for PATIENT COUNSELING INFORMATION. You can open a PDF document (no drag n' drop support), and it will promptly display the current metadata and then allows quick and easy modification of any fields.Īdept PDF Info Changer also permits you to hide the toolbar, menu bar, and window UI, display the document title, resize the window to the first-page size, and center it. Astellas represents addresses all seven elements of an effective compliance program and that is designed to address compliance with Federal health care program requirements (Compliance Program). Once you run Adept PDF Info Changer, you are provided with a single window interface that contains all the fields needed to change the PDF file properties/metadata information, including author, title, subject, keywords, etc. 95 A,127ĪNDHERI KURLA RD, VILLAGE CHAKALA, ANDHERI (EAST), MUMBAI, Mumbai City, Maharashtra.Adept PDF Info Changer provides a simple way to change various aspects of a PDF document easily without the need of Adobe Acrobat and Reader. Please read the description and table of contents of this research report given below to check whether it meets your research requirements. information (collectively Financial Records) to estimate my income in conjunction with determining my eligibility for assistance from the Astellas Patient Assistance Program. (PDF) which allows one person to use this report. The registered office of Astellas Pharma India Private Limited is at UNIT NO. Strategy, SWOT and Corporate Finance Report report is published on December 30. The Corporate Identification Number (CIN) of Astellas Pharma India Private Limited is U85192MH2008FTC188194. Also, as per our records, its last balance sheet was prepared for the period ending on 31 March, 2021.Īstellas Pharma India Private Limited has three directors - Daowen Soon, Sanjay Sharma, and others.
The last reported AGM (Annual General Meeting) of Astellas Pharma India Private Limited, per our records, was held on 28 September, 2021. The current status of Astellas Pharma India Private Limited is - Active. It's authorized share capital is INR 50.00 cr and the total paid-up capital is INR 33.69 cr. It is classified as a private subsidiary of a foreign copmany and is located in Mumbai City, Maharashtra. January 20222 Information Classification: General Summary The 40th annual J.P. Press Release Astellas Announces Status of Acquisition of Own Shares Tokyo, September 1, 2017- Astellas Pharma Inc. OVERVIEW - ASTELLAS PHARMA INDIA PRIVATE LIMITEDĪstellas Pharma India Private Limited is an unlisted private company incorporated on 14 November, 2008. These highlights do not include all the information needed to use PROGRAF ® safely and effectively.
0 kommentar(er)
